You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Merck
Medtronic
Dow

Last Updated: April 3, 2020

DrugPatentWatch Database Preview

ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Ancef In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Ancef In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Ancef In Dextrose 5% In Plastic Container

A generic version of ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Start Trial

Summary for ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-003 Jun 8, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-004 Jun 8, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Merck
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.